Long-term management of depression

Robert M A Hirschfeld, Alan F. Schatzberg

Research output: Contribution to journalArticle

Abstract

Major depression is often a chronic and recurrent disorder. Findings from a landmark study, the Pittsburgh Study of Maintenance Therapies in Recurrent Depression, demonstrate that full doses of antidepressants prevent recurrent depression and that maintenance therapy lasting at least 5 years may be required for patients with severly recurrent disease. In addition, psychotherapy is a useful adjunct to antidepressant maintenance therapy in prolonging the duration between recurrent episodes. The currently accepted approach to preventing recurrent depression is to treat the acute episode to full remission and follow up by maintaining the patient on the full, acute dose used to achieve the initial response. The selective serotonin reuptake inhibitors (SSRIs) have been studied in recurrent depression and are rational choices for initial maintenance therapy because of demonstrated efficacy, safety, and tolerance during long-term therapy.

Original languageEnglish (US)
JournalThe American Journal of Medicine
Volume97
Issue number6 SUPPL. 1
DOIs
StatePublished - Dec 19 1994

Fingerprint

Depression
Antidepressive Agents
Therapeutics
Serotonin Uptake Inhibitors
Psychotherapy
Safety

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Long-term management of depression. / Hirschfeld, Robert M A; Schatzberg, Alan F.

In: The American Journal of Medicine, Vol. 97, No. 6 SUPPL. 1, 19.12.1994.

Research output: Contribution to journalArticle

Hirschfeld, Robert M A ; Schatzberg, Alan F. / Long-term management of depression. In: The American Journal of Medicine. 1994 ; Vol. 97, No. 6 SUPPL. 1.
@article{d90695d742a04776bbe9205185eeaa37,
title = "Long-term management of depression",
abstract = "Major depression is often a chronic and recurrent disorder. Findings from a landmark study, the Pittsburgh Study of Maintenance Therapies in Recurrent Depression, demonstrate that full doses of antidepressants prevent recurrent depression and that maintenance therapy lasting at least 5 years may be required for patients with severly recurrent disease. In addition, psychotherapy is a useful adjunct to antidepressant maintenance therapy in prolonging the duration between recurrent episodes. The currently accepted approach to preventing recurrent depression is to treat the acute episode to full remission and follow up by maintaining the patient on the full, acute dose used to achieve the initial response. The selective serotonin reuptake inhibitors (SSRIs) have been studied in recurrent depression and are rational choices for initial maintenance therapy because of demonstrated efficacy, safety, and tolerance during long-term therapy.",
author = "Hirschfeld, {Robert M A} and Schatzberg, {Alan F.}",
year = "1994",
month = "12",
day = "19",
doi = "10.1016/0002-9343(94)90361-1",
language = "English (US)",
volume = "97",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "6 SUPPL. 1",

}

TY - JOUR

T1 - Long-term management of depression

AU - Hirschfeld, Robert M A

AU - Schatzberg, Alan F.

PY - 1994/12/19

Y1 - 1994/12/19

N2 - Major depression is often a chronic and recurrent disorder. Findings from a landmark study, the Pittsburgh Study of Maintenance Therapies in Recurrent Depression, demonstrate that full doses of antidepressants prevent recurrent depression and that maintenance therapy lasting at least 5 years may be required for patients with severly recurrent disease. In addition, psychotherapy is a useful adjunct to antidepressant maintenance therapy in prolonging the duration between recurrent episodes. The currently accepted approach to preventing recurrent depression is to treat the acute episode to full remission and follow up by maintaining the patient on the full, acute dose used to achieve the initial response. The selective serotonin reuptake inhibitors (SSRIs) have been studied in recurrent depression and are rational choices for initial maintenance therapy because of demonstrated efficacy, safety, and tolerance during long-term therapy.

AB - Major depression is often a chronic and recurrent disorder. Findings from a landmark study, the Pittsburgh Study of Maintenance Therapies in Recurrent Depression, demonstrate that full doses of antidepressants prevent recurrent depression and that maintenance therapy lasting at least 5 years may be required for patients with severly recurrent disease. In addition, psychotherapy is a useful adjunct to antidepressant maintenance therapy in prolonging the duration between recurrent episodes. The currently accepted approach to preventing recurrent depression is to treat the acute episode to full remission and follow up by maintaining the patient on the full, acute dose used to achieve the initial response. The selective serotonin reuptake inhibitors (SSRIs) have been studied in recurrent depression and are rational choices for initial maintenance therapy because of demonstrated efficacy, safety, and tolerance during long-term therapy.

UR - http://www.scopus.com/inward/record.url?scp=43949152137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949152137&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(94)90361-1

DO - 10.1016/0002-9343(94)90361-1

M3 - Article

VL - 97

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 6 SUPPL. 1

ER -